早期口咽鳞癌经口机器人手术与非机器人手术生存比较
该回顾性队列研究基于美国国家癌症数据库2010至2015年确诊的临床T1-T2期口咽鳞癌患者,比较经口机器人手术与非机器人手术的长期结局。
要点
- 已知HPV状态患者中机器人手术与更优总生存相关(HR 0.74,95%CI 0.61-0.90)。
核心结论
- 在早期口咽鳞癌患者中,经口机器人手术与非机器人手术相比,与更好的手术结局和生存相关。
- 作者认为有必要开展对比性随机试验进行验证。
研究设计与样本
- 回顾性队列比较效果分析,使用美国国家癌症数据库数据。
- 纳入2010年1月1日至2015年12月31日确诊的临床T1和T2期口咽鳞癌患者,共9745例,其中2694例(27.6%)接受经口机器人手术。
- 在已知HPV状态的患者中行多变量Cox比例风险回归和倾向评分匹配分析。
临床怎么用
- 对于早期口咽鳞癌,经口机器人手术可能作为与非机器人手术相比改善手术结局和生存的选择。
- 机器人手术与更低的切缘阳性率和辅助放化疗使用率相关,可能减少治疗相关负担。
局限性
- 本研究为回顾性队列分析,存在选择偏倚等混杂因素可能。
- 作者指出需要对比性随机试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Transoral robotic surgery has been widely adopted since approval by the US Food and Drug Administration in December 2009, despite limited comparative data. OBJECTIVE: To compare the long-term outcomes of transoral robotic surgery with those of nonrobotic surgery for patients with early-stage oropharyngeal cancer. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort comparative effectiveness analysis was performed of patients in the National Cancer Database with clinical T1 and T2 oropharyngeal squamous cell carcinoma diagnosed between January 1, 2010, and December 31, 2015, who underwent definitive robotic and nonrobotic surgery. Multivariable Cox proportional hazards regression analysis and propensity score matching were performed in patients with known human papillomavirus status to adjust for patient- and disease-related covariates. Survival after robotic and nonrobotic surgery was also compared in 3 unrelated cancers: prostate, endometrial, and cervical cancer. Statistical analysis was performed from April 10, 2019, to May 21, 2020. MAIN OUTCOMES AND MEASURES: Overall survival. RESULTS: Of 9745 patients (7652 men [78.5%]; mean [SD] age, 58.8 [9.6] years) who met inclusion criteria, 2694 (27.6%) underwent transoral robotic surgery. There was a significant increase in the use of robotic surgery from 18.3% (240 of 1309) to 35.5% (654 of 1841) of all surgical procedures for T1 and T2 oropharyngeal cancers from 2010 to 2015 (P = .003). Robotic surgery was associated with lower rates of positive surgical margins (12.5% [218 of 1746] vs 20.3% [471 of 2325]; P < .001) and lower use of adjuvant chemoradiotherapy (28.6% [500 of 1746] vs 35.7% [831 of 2325]; P < .001). Among 4071 patients with known human papillomavirus status, robotic surgery was associated with improved overall survival compared with nonrobotic surgery in multivariable Cox proportional hazards regression (hazard ratio [HR], 0.74; 95 CI, 0.61-0.90; P = .002). Similar results were seen when analyzing only the subset of facilities offering both robotic and nonrobotic surgery. The 5-year overall survival was 84.8% vs 80.3% among patients undergoing robotic vs nonrobotic surgery in propensity score-matched cohorts (P = .001). By contrast, there was no evidence that robotic surgery was associated with improved survival in other cancers, such as prostate cancer (HR, 0.92; 95% CI, 0.79-1.07; P = .26), endometrial cancer (HR, 0.97; 95% CI, 0.90-1.04; P = .36), and cervical cancer (HR, 1.27; 95% CI, 0.96-1.69; P = .10). CONCLUSIONS AND RELEVANCE: This study suggests that transoral robotic surgery was associated with improved surgical outcomes and survival compared with nonrobotic surgery in patients with early-stage oropharyngeal cancer. Evaluation in comparative randomized trials is warranted.
引用
- Nguyen AT, Luu M, Mallen-St Clair J, et al. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma. JAMA Oncol. 2020. PMID: 32816023. doi:10.1001/jamaoncol.2020.3172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。